St. Jude takes No. 2 spot in ICD market

10/19/2006 | Twincities.com · TheStreet.com

Although its implantable cardioverter defibrillator sales declined by 2%, St. Jude Medical beat analysts' expectations when it posted $116 million in earnings. The company's CEO, Dan Starks, also announced that the company's third quarter was "the tipping point when St. Jude became the clear No. 2 in selling pacemakers and ICDs," overtaking Boston Scientific Corp.

View Full Article in:

Twincities.com · TheStreet.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI